Remove deals price
article thumbnail

How Hospice Valuations Are Shaping Up in 2024

Hospice News

When it comes to hospice acquisitions, buyers and sellers expectations on price tags are becoming more aligned. A surge of deals in 2021 and 2022 led to record-high valuations in the space with multiples reaching in excess of 30x in some instances. Selling prices are most commonly measured in multiples of EBITDA, according to Kulik.

2024 278
article thumbnail

Hospice Multiples Unlikely to Drop

Hospice News

A turbulent economy and slight cool-down in deal activity early in the year have led some to question whether the record-high valuations for hospice assets will start to tumble. Williams indicated that VITAS would consider any prospective deals on a case-by-case basis, and to date, the company has not announced any acquisitions.

Hospice 252
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Addus Taking a Cautious Approach to Hospice Deals

Hospice News

Valuations in the hospice space have led Addus Homecare (Nasdaq: ADUS) to take a more conservative approach to hospice transactions as it actively seeks home health and personal care deals. Since then the price tags have reportedly come down, but they haven’t gone far enough, according to Addus President and COO Brad Bickham.

Hospice 264
article thumbnail

The Pennant Group Acquires Signature Healthcare at Home in $80M Deal

Hospice News

NASDAQ: PNTG) has agreed to acquire Signature Healthcare at Home’s hospice and home health assets for a price tag of $80 million. This deal is a great example of that.” The deal will help widen career growth opportunities for current and future employees, according to Signature President Mary Kofstad. The Pennant Group Inc.

article thumbnail

Option Care, Amedisys Deal Reveals a ‘Whole Different Landscape’ for Hospice Providers 

Hospice News

This deal also comes on the heels of two other huge transactions, Humana Inc.’s per Amedisys share, based on Option Care Health’s May 2 closing stock price. Amedisys stock price has taken a beating over the past couple of years, which has made it a very attractive target from a pricing standpoint.

Hospice 246
article thumbnail

BrightSpring Projects ‘Robust, Accretive’ Hospice, Home Health M&A Pipeline

Hospice News

Tuck-in deals and de novos have been key to BrightSpring’s strategic growth. We have tremendous deal volume.” Its most recent transaction came on Wednesday when BrightSpring closed its acquisition of the Florida-based nonprofit Haven Hospice for a price tag of $60 million.

Hospice 289
article thumbnail

The Pennant Group Leverages Partnerships, Deals to Spur Expansion

Hospice News

The Pennant Group agreed to acquire Signature Healthcare at Home’s hospice and home health assets for a price tag of $80 million. The post The Pennant Group Leverages Partnerships, Deals to Spur Expansion appeared first on Hospice News.

Homecare 264